Related Experiment Video
Updated: Jul 19, 2026

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
Published on: August 1, 2025
Cannabinoid self-administration increases dopamine release in the nucleus accumbens
Paola Fadda1, Maria Scherma, Maria Sabrina Spano
1Department of Neuroscience, University of Cagliari, Monserrato-Cagliari, Italy. pfadda@unica.it
Dopamine release significantly increased during cannabinoid self-administration in rats, indicating its crucial role in mediating the reinforcing effects of cannabinoids. This enhanced dopamine activity in the mesolimbic pathway underlies cannabinoid-seeking behavior.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Cannabinoids produce rewarding effects, but the underlying neurobiological mechanisms are not fully understood.
- The mesolimbic dopamine pathway is implicated in reward and motivation, including drug-seeking behaviors.
Purpose of the Study:
- To investigate the role of dopamine release in mediating the reinforcing effects of cannabinoid self-administration.
- To understand how dopamine influences cannabinoid intake and seeking behavior.
Main Methods:
- Measuring extracellular dopamine levels in the nucleus accumbens shell of rats during self-administration of a cannabinoid agonist (WIN 55,212-2).
- Comparing dopamine levels during cannabinoid intake versus vehicle self-administration.
Main Results:
- A significant positive correlation was observed between extracellular dopamine levels and bar-pressing rates in rats self-administering cannabinoids.
- Dopamine levels increased significantly above basal values during cannabinoid intake.
- Dopamine levels remained unchanged when rats self-administered the vehicle, confirming the cannabinoid-specific effect.
Conclusions:
- Enhanced activity of the mesolimbic dopamine pathway is critical for cannabinoid-seeking behavior.
- Dopamine neurotransmission plays a key role in mediating the reinforcing properties of cannabinoids.
More Related Videos
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
06:40Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry (CIS-FSCV) to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine
Published on: April 23, 2020
Related Concept Videos
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drug Abuse and Addiction: Pharmacological Phenomena
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Regulation of Food Intake